Benjamin Burnett Analyst PerformanceAnalyst at Wells Fargo & CompanyBenjamin Burnett is a stock analyst at Wells Fargo & Company in the medical sector, covering 25 publicly traded companies. Over the past year, Benjamin Burnett has issued 59 stock ratings, including strong buy, buy, and hold recommendations. While full access to Benjamin Burnett's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Benjamin Burnett's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings74 Last 6 YearsBuy Recommendations73.97% 54 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution73RatingsDistribution of strong buy, buy, hold, and sell ratings by Benjamin Burnett.RatingPercentageCount Strong Buy2.7%2 ratings Buy71.2%52 ratings Hold26.0%19 ratings Sell0.0%0 ratingsOut of 73 total stock ratings issued by Benjamin Burnett at Wells Fargo & Company, the majority (71.2%) have been Buy recommendations, followed by 26.0% Hold and 2.7% Strong Buy.Best & Worst CallsBest Call0000.0%BLUEMar 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EFTRNov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ25 companiesBenjamin Burnett, an analyst at Wells Fargo & Company, currently covers 25 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical25 companies100.0%Benjamin Burnett of Wells Fargo & Company specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE18 companies72.0%MED - DRUGS4 companies16.0%MED - GENERIC DRG1 company4.0%PHARMACEUTICAL PREPARATIONS1 company4.0%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company4.0% Benjamin Burnett's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAMPHAmphastar Pharmaceuticals5/14/2026Reiterated Rating$18.32$19.00Equal Weight$0.0000.00% ROILQDALiquidia5/12/2026Boost Price Target$53.13$62.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics5/8/2026Boost Price Target$71.29$95.00Overweight$0.0000.00% ROIINSMInsmed5/8/2026Lower Price Target$104.53$160.00Overweight$0.0000.00% ROIMNKDMannKind5/7/2026Boost Price Target$3.56$10.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics5/7/2026Upgrade$596.76$735.00Overweight$0.0000.00% ROIRAREUltragenyx Pharmaceutical5/6/2026Boost Price Target$25.71$47.00Overweight$0.0000.00% ROIALKSAlkermes5/6/2026Boost Price Target$36.11$44.00Overweight$0.0000.00% ROIAXSMAxsome Therapeutics5/5/2026Boost Price Target$229.12$255.00Overweight$0.0000.00% ROIMNKDMannKind4/28/2026Boost Price Target$2.72$8.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CNTACentessa Pharmaceuticals4/20/2026Downgrade$39.61$42.00Equal Weight$0.0000.00% ROIUTHRUnited Therapeutics3/31/2026Boost Price Target$590.17$575.00Equal Weight$0.0000.00% ROIWVEWAVE Life Sciences3/27/2026Lower Price Target$6.20$13.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics3/23/2026Boost Price Target$531.66$486.00Equal Weight$0.0000.00% ROILQDALiquidia3/23/2026Boost Price Target$36.89$51.00Overweight$0.0000.00% ROIINSMInsmed3/23/2026Lower Price Target$144.80$175.00Overweight$0.0000.00% ROIRAPPRapport Therapeutics3/11/2026Boost Price Target$30.44$46.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals3/10/2026Boost Price Target$60.06$68.00Overweight$0.0000.00% ROILQDALiquidia3/6/2026Boost Price Target$34.24$44.00Overweight$0.0000.00% ROIKROSKeros Therapeutics3/5/2026Lower Price Target$12.30$20.00Overweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals2/27/2026Lower Price Target$22.57$30.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals2/27/2026Boost Price Target$43.41$49.00Overweight$0.0000.00% ROIMNKDMannKind2/27/2026Lower Price Target$3.28$7.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics2/26/2026Boost Price Target$503.34$466.00Equal Weight$0.0000.00% ROIALKSAlkermes2/26/2026Boost Price Target$30.41$43.00Overweight$0.0000.00% ROIAXSMAxsome Therapeutics2/24/2026Boost Price Target$174.76$202.00Overweight$0.0000.00% ROIINSMInsmed2/20/2026Lower Price Target$161.00$208.00Overweight$0.0000.00% ROIPRAXPraxis Precision Medicines2/20/2026Set Price Target$331.61$305.00Equal Weight$0.0000.00% ROIPTCTPTC Therapeutics2/20/2026Lower Price Target$69.90$86.00Overweight$0.0000.00% ROIWVEWAVE Life Sciences2/12/2026Lower Price Target$12.79$27.00Overweight$0.0000.00% ROIPRAXPraxis Precision Medicines2/2/2026Initiated Coverage$314.00$282.00Equal Weight$0.0000.00% ROIRAPPRapport Therapeutics2/2/2026Initiated Coverage$26.61$43.00Overweight$0.0000.00% ROIAXSMAxsome Therapeutics1/13/2026Boost Price Target$176.82$193.00Overweight$0.0000.00% ROIRAREUltragenyx Pharmaceutical12/30/2025Lower Price Target$19.72$45.00Overweight$0.0000.00% ROIINSMInsmed12/18/2025Set Price Target$198.46$195.00$0.0000.00% ROISVRASavara12/18/2025Boost Price Target$6.06$9.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals12/11/2025Boost Price Target$43.85$48.00Overweight$0.0000.00% ROIWVEWAVE Life Sciences12/9/2025Boost Price Target$18.52$29.00Overweight$0.0000.00% ROIAVDLAvadel Pharmaceuticals11/20/2025Boost Price Target$23.10$22.50Equal Weight$0.0000.00% ROICNTACentessa Pharmaceuticals11/13/2025Boost Price Target$26.07$35.00Overweight$0.0000.00% ROIRead now. Do not delete. You’ve been warned. (Ad)Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.Don’t be left behind. Click here now.ALKSAlkermes11/13/2025Lower Price Target$31.19$37.00Overweight$0.0000.00% ROIWVEWAVE Life Sciences11/11/2025Lower Price Target$7.18$16.00Overweight$0.0000.00% ROIMNKDMannKind11/11/2025Lower Price Target$5.22$8.00Overweight$0.0000.00% ROIKROSKeros Therapeutics11/11/2025Lower Price Target$16.73$23.00Overweight$0.0000.00% ROICNTACentessa Pharmaceuticals11/7/2025Lower Price Target$22.12$30.00Overweight$0.0000.00% ROIAVDLAvadel Pharmaceuticals11/7/2025Boost Price Target$18.73$20.00Equal Weight$0.0000.00% ROIAXSMAxsome Therapeutics11/4/2025Lower Price Target$135.75$157.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals11/4/2025Reiterated Rating$41.12$44.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics10/30/2025Boost Price Target$452.36$423.00Equal Weight$0.0000.00% ROIALKSAlkermes10/29/2025Lower Price Target$31.16$42.00Overweight$0.0000.00% ROICNTACentessa Pharmaceuticals9/3/2025Initiated Coverage$17.27$31.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals9/3/2025Initiated Coverage$39.30$48.00Overweight$0.0000.00% ROIALKSAlkermes9/3/2025Upgrade$30.00Strong-Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals9/3/2025Upgrade$14.66Hold$0.0000.00% ROIAXSMAxsome Therapeutics9/3/2025Upgrade$122.00Strong-Buy$0.0000.00% ROIAXSMAxsome Therapeutics9/2/2025Initiated Coverage$123.47$163.00Overweight$0.0000.00% ROIAVDLAvadel Pharmaceuticals9/2/2025Initiated Coverage$14.98$16.00Equal Weight$0.0000.00% ROIALKSAlkermes9/2/2025Initiated Coverage$29.40$44.00Overweight$0.0000.00% ROIRVMDRevolution Medicines4/1/2025Lower Price Target$35.36$64.00Buy$00.0000.00% ROIFATEFate Therapeutics3/6/2025Lower Price Target$0.98$3.00Hold$0.0000.00% ROIRVMDRevolution Medicines2/27/2025Lower Price Target$40.94$78.00Buy$000.0000.00% ROICRSPCRISPR Therapeutics2/13/2025Lower Price Target$42.61$49.00Hold$00.0000.00% ROIIRONDisc Medicine1/24/2025Boost Price Target$57.07$94.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
